Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion.
about
Does central sensitization help explain idiopathic overactive bladder?Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder.The female urinary microbiome: a comparison of women with and without urgency urinary incontinence.How to define a refractory idiopathic overactive bladder?Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity?Somatic syndromes and chronic pain in women with overactive bladder.Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013.Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome.Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms.European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder.Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.
P2860
Q26744440-BD7AF13B-E612-432D-ACEB-D70E165147E7Q34039459-461E8F1A-B5E4-4B69-B0CA-DECA2A48C9E3Q34165475-9C7038BE-A667-4CBD-83DB-D377994E9E0EQ35024928-01B7191E-1924-4D54-9913-556787E1D381Q36090770-7ABEDE8B-7B20-42C0-A1E0-1FE28B5317A9Q36910650-052ABFC7-1745-4705-BD36-507F5435F5A8Q37127647-24D3C48B-0F8D-410D-B74F-6009F012F96FQ37547749-DC9E3C9E-3A64-4EC2-9429-5BD7DCC52656Q38819016-2EBC6B06-58F7-412A-A510-8D99711C0796Q39189283-5DE3420B-3DA9-477F-BBD7-4884E245BAE1Q43815698-8E04F5F0-E3FA-4C93-9597-B466C36C01A3Q44037004-CC14D2D8-802B-439A-ADC9-3FB430F5F671Q47899127-586D43B6-DBE9-4307-81F8-65D1139D387DQ53134307-37B732CF-1914-41BB-ACF3-518E03C2B7EB
P2860
Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Can we predict which patient w ...... dder? A think tank discussion.
@en
Can we predict which patient w ...... dder? A think tank discussion.
@nl
type
label
Can we predict which patient w ...... dder? A think tank discussion.
@en
Can we predict which patient w ...... dder? A think tank discussion.
@nl
prefLabel
Can we predict which patient w ...... dder? A think tank discussion.
@en
Can we predict which patient w ...... dder? A think tank discussion.
@nl
P2093
P356
P1476
Can we predict which patient w ...... adder? A think tank discussion
@en
P2093
Alex T L Lin
Ian W Mills
Kate H Moore
Michael Oefelein
P304
P356
10.1002/NAU.20910
P577
2010-04-01T00:00:00Z